StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$99.25−5.59 (-5.33%)

Close on Nov 20, 2026Market cap $4.43BP/E –Yield –

Grail free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Grail's free cash flow for the twelve months ending Jun 30, 2026 was -$296.16M. For fiscal 2025 it was -$299.92M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$299.92M–
FY2024Dec 31, 2024-$582.36M–
FY2023Dec 31, 2023-$608.69M–
FY2022Jan 1, 2023-$584.17M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$81.16M–
Q1 FY2026Mar 31, 2026-$87.49M–
Q4 FY2025Dec 31, 2025-$63.88M–
Q3 FY2025Sep 30, 2025-$63.63M–
Q2 FY2025Jun 30, 2025-$77.33M–
Q1 FY2025Mar 31, 2025-$95.07M–
Q4 FY2024Dec 31, 2024-$93.79M–
Q3 FY2024Sep 30, 2024-$105.55M–
Q2 FY2024Jun 30, 2024-$173.19M–
Q1 FY2024Mar 31, 2024-$209.83M–

More Grail figures

See a number that looks wrong?